Literature DB >> 21784458

Hypertriglyceridemia as a possible predictor of early neurological deterioration in acute lacunar stroke.

Hyung-Min Kwon1, Jae-Sung Lim, Hong-Kyun Park, Yong-Seok Lee.   

Abstract

BACKGROUND: Early neurological deterioration (END) is not uncommon in lacunar stroke and may lead to poor outcome. Several predictors for END have been previously reported, however, well-designed, MRI-based studies are rare in lacunar stroke. We prospectively enrolled consecutive patients with acute lacunar infarct (≤ 48 h) confirmed by MRI to investigate possible predictors for END.
METHODS: Demographic data, vascular risk factors, laboratory findings, and neurological status were obtained. END was defined as an increment of the National Institutes of Health Stroke Scale (NIHSS), ≥ 1 in motor power, or ≥ 2 in any scores during the first week.
RESULTS: A total of 131 patients were recruited and 17 (13%) developed END after admission. Univariate analysis revealed that diabetes, systolic blood pressure, triglyceride (TG), total cholesterol, low density lipoprotein-cholesterol, and homocysteine were associated with END. After multiple logistic regression analysis, the highest quartile of TG level (>145 mg/dL) remained independent [adjusted odds ratio (OR) = 11.46, 95% confidence interval (CI) = 1.07-122.87, P = 0.044].
CONCLUSION: Hypertriglycedemia may be a possible predictor for END in acute lacunar stroke. Thrombogenecity and microcirculatory disturbance augmented by hypertriglyceridemia may be suggested as potential mechanisms. Further studies are warranted to confirm these results. Pathophysiological and therapeutic considerations remain to be determined.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21784458     DOI: 10.1016/j.jns.2011.06.057

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Nocturnal Desaturation is Associated With Neurological Deterioration Following Ischemic Stroke: A Retrospective Observational Study.

Authors:  Tae Jung Kim; Sang-Bae Ko; Han-Gil Jeong; Chi Kyung Kim; Yerim Kim; Kiwoong Nam; Heejung Mo; Sang Joon An; H Alex Choi; Byung-Woo Yoon
Journal:  J Clin Sleep Med       Date:  2017-11-15       Impact factor: 4.062

2.  Total MRI burden of cerebral vessel disease correlates with the progression in patients with acute single small subcortical strokes.

Authors:  Jingwen Jiang; Xiaojun Huang; Yu Zhang; Weiping Deng; Fanxia Shen; Jianrong Liu
Journal:  Brain Behav       Date:  2018-12-03       Impact factor: 2.708

3.  Decreasing serum 25-hydroxyvitamin D levels and risk of early neurological deterioration in patients with ischemic stroke.

Authors:  Wei Hu; Dezhi Liu; Qin Li; Li Wang; Qiqiang Tang; Guoping Wang
Journal:  Brain Behav       Date:  2019-02-06       Impact factor: 2.708

4.  Fasting and Non-Fasting Triglycerides in Patients With Acute Ischemic Stroke.

Authors:  Jun Yup Kim; Keon-Joo Lee; Jihoon Kang; Beom Joon Kim; Moon-Ku Han; Kyusik Kang; Jong-Moo Park; Tai Hwan Park; Hong-Kyun Park; Yong-Jin Cho; Keun-Sik Hong; Kyung Bok Lee; Myung Suk Jang; Ji Sung Lee; Juneyoung Lee; Hee-Joon Bae
Journal:  J Korean Med Sci       Date:  2022-04-04       Impact factor: 2.153

5.  Developing and validating a predictive model for stroke progression.

Authors:  L E Craig; O Wu; H Gilmour; M Barber; P Langhorne
Journal:  Cerebrovasc Dis Extra       Date:  2011-12-03

6.  Metabolic Syndrome Augments the Risk of Early Neurological Deterioration in Acute Ischemic Stroke Patients Independent of Inflammatory Mediators: A Hospital-Based Prospective Study.

Authors:  Xiaohao Zhang; Zhiguang Sun; Caixia Ding; Yinyan Tang; Xuemei Jiang; Yi Xie; Chuanyou Li; Lankun Zhang; Dan Hu; Tingting Li; Gelin Xu; Lei Sheng
Journal:  Oxid Med Cell Longev       Date:  2016-03-29       Impact factor: 6.543

7.  Early neurological deterioration during the acute phase as a predictor of long-term outcome after first-ever ischemic stroke.

Authors:  He-Hong Geng; Qiang Wang; Bo Li; Bin-Bin Cui; Yong-Ping Jin; Rong-Li Fu; Qing Zhang; Jing-Jie Wang; Pei-Xi Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.